retatrutide 30mg Retatrutide-RUO GLP-3RT 30mg Retatrutide — 99%

Reduced frequency: Some individuals consume GLP-1 receptor agonists less frequently than the standard dosing schedule (one injection per week)

Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight

Most people sense a pump in their mood and confidence as their body transforms

For diabetes (T2D) indication, both Mounjaro and Wegovy are covered widely

Available at: Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S, et al

Rapid weight reduction often results in loss of both fat and lean tissue, potentially compromising metabolic health and physical function